Influence of substituted quinones on the excretory function of the rat kidney and evaluation of the prospects of their use as potential diuretics
DOI:
https://doi.org/10.26641/2307-0404.2024.2.307457Ключові слова:
substituted quinones, diuretic activity, diuretic index, urinary electrolyte excretionАнотація
Diuretics are widely used to treat pathologies of various genesis. However, the development of side effects during their long-term use remains a problem of traditional treatment regimens. The search for diuretics that would be aimed at inhibiting a key target molecule that is involved in the regulation of salt or water balance in the kidney, and certainly have a low level of toxicity and side effects, is an urgent task for researchers. Our preliminary screening of substituted quinones using in silico and in vitro methodology identified a number of effective compounds that outperform or compete with diuretics. The compounds are not "classic" carbonic anhydrase II inhibitors, but the pronounced diuretic effect of a number of compounds requires additional explanation. Therefore, the aim of the work was to study the effect of substituted quinones on the excretory function of rat kidneys to assess the prospects of their further structural modification and use as potential diuretics. Considering the experimental data, it should be noted that compounds AVD-6, AVD-7, AVD-8 and AVD-9 have pronounced diuretic activity. Thus, according to indicators of excretory indices of electrolytes, it is possible to note the predominant influence of compounds AVD-6, AVD-7, AVD-8 and AVD-9 on excretion of sodium, potassium and chlorine from the body. Compounds AVD-6, AVD-7, AVD-8 and AVD-9, in contrast to Hydrochlorothiazide, which blocks carbonic anhydrase in the proximal part of the convoluted tubules and accelerates the excretion of potassium with from the urine, have a much lower excretory index as for these ions. Thus, our conducted research made it possible to identify a new, little-known class of hybrid molecular structures, namely (N'-(4-[(aroyloxy)imino]cyclohexa-2,5-dien-1-ylidene) aroylhydrazides (AVD-6, AVD-7, AVD-8 and AVD-9), which, in addition to affecting the excretory function of the kidneys, have significant diuretic activity and are potential diuretics.
Посилання
Akbari P, Khorasani-Zadeh A. Thiazide Diuretics. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Feb 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532918/
Roush GC, Sica DA. Diuretics for Hypertension: A Review and Update. Am J Hypertension. 2016:29(10):1130-7. doi: https://doi.org/10.1093/ajh/hpw030
Trujillo H, Caravaca-Fontán F, Caro J, Morales E, Praga M. The Forgotten Antiproteinuric Properties of Diuretics. Am J Nephrol. 2021;52(6):435-49. doi: https://doi.org/10.1159/000517020
Kehrenberg MCA, Bachmann HS. Diuretics: a contemporary pharmacological classification? Naunyn-Schmiedeberg's Arch Pharmacol. 2022;395:619-27. doi: https://doi.org/10.1007/s00210-022-02228-0
Livero FA, Menetrier JV, Lourenco ELB, Ju-nior AG. Cellular and Molecular Mechanisms of Diuretic Plants: An Overview. Curr Pharm Des. 2017;23(8):1247-52. doi: https://doi.org/10.2174/1381612822666161014114437
Denton JS, Pao AC, Maduke M. Novel diuretic targets. AJP: Renal Physiology. 2013;305(7):F931-F942. doi: https://doi.org/10.1152/ajprenal.00230.2013
Titko T, Perekhoda L, Drapak I, Tsapko Y. Mo-dern trends in diuretics development. Eur J Medicinal Chemistry. 2020;208:112855. doi: https://doi.org/10.1016/j.ejmech.2020.112855
Zhao Y, Cao E. Structural Pharmacology of Ca-tion-Chloride Cotransporters. Membranes. 2022;12:1206. doi: https://doi.org/10.3390/membranes12121206
Dhondup T, Qian Q. Acid-Base and Electrolyte Disorders in Patients with and without Chronic Kidney Disease: An Update. Kidney Dis (Basel). 2017;3(4):136-48. doi: https://doi.org/10.1159/000479968
10.Sokolova K, Stavytskyi V, Konovalova S, Podpletnya O, Kovalenko S, Avdeenko A. Design and search for prospective diuretics (CA II Inhibitors) among aroylhydrazones of esters quinone oxime using in silico and in vivo methodology. Medicni perspektivi [Internet]. 2022Dec.29;27(4):27-3. doi: https://doi.org/10.26641/2307-0404.2022.4.271120
Sokolova KV, Podpletnya OA, Konovalova SО, Avdeenko AP, Komarovska-Porokhnyaves OZ, Lubе-nets VI, et al. N-Arylslfonyl-2-aroylamino-1,4-quinone imines and their hydrogenated analogues: toxicity pre-diction and prospects for use as diuretic agents. Medicni perspektivi. 2023;28(2):20-8. doi: https://doi.org/10.26641/2307-0404.2023.2.283152
European convention for the protection of vertebrate animal used for experimental and other scientific purposes [Internet]. Council of Europe, Strasbourg. 1986 [cited 2024 Feb 23]. 11 р. Available from: https://rm.coe.int/168007a67b
Stefanov OV. [Preclinical studies of medicines]. Kyiv: Avitsena; 2001. 528 р. Ukrainian.
Strahova OP, Androsov OI. [Statistical methods of processing the results of medical and biological research]. Lviv; 2021. 164 p. Ukrainian.
Sica DA, Carter B, Cushman W, Hamm L. Thia-zide and loop diuretics. J Clin Hypertens (Greenwich). 2011;13(9):639-43. doi: https://doi.org/10.1111/j.1751-7176.2011.00512.x
Horisberger JD, Giebisch G. Potassium-sparing diuretics. Ren Physiol. 1987;10(3-4):198-220. doi: https://doi.org/10.1159/000173130
Bolton JL, Dunlap T. Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects. Chem Res Toxicol. 2017;30(1):13-37. doi: https://doi.org/10.1021/acs.chemrestox.6b00256
Antomonov MYu. [Mathematical processing and analysis of medical and biological data]. Кyiv: MYCz "Medynform"; 2018. р. 579. Ukrainian.
Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016 Mar;7(2):27-31. doi: https://doi.org/10.4103/0976-0105.177703
Lunova HH, Lipkan HM, Viunytska LV, et al. [Clinical biochemistry: textbook: in 3 vol.] Lviv: PP «Mahnoliia 2006; 2023;2:372. Ukrainian.
Pickkers P, Garcha RS, Schachter M, Smits P, Hughes AD. Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide. Hypertension. 1999 Apr;33(4):1043-8. doi: https://doi.org/10.1161/01.hyp.33.4.1043
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2024 Медичні перспективи
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.